Browse
Explore conditions, clinical trials, and the organisations running them.
Up to: Cortisone reductase deficiency
Cortisone reductase deficiency 2
Decreased activity of the enzyme 11-beta-hydroxysteroid dehydrogenase type 1 due to inactivating mutation(s) in the HSD11B1 gene. The condition is characterized by hyperandrogenism as a result of increased adrenocorticotropic hormone stimulation of the adrenal gland due to failure of cortisol-mediated down-regulation, and is clinically indistinguishable from H6PD deficiency.
This condition has no sub-types.